Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its.
Velocity Purchases 200 Battery-Electric Trucks for Leasing Operations truckinginfo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from truckinginfo.com Daily Mail and Mail on Sunday newspapers.